Lupin receives US FDA approval for arthritis drug
The company has received marketing approval for Celecoxib, a generic version of GD Searle LLC's (a subsidiary of Pfizer Inc) Celebrex capsules
 "Lupin receives US FDA approval for arthritis drug")
Lupin's Celecoxib capsules are indicated for osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis in patients 2 years and older; ankylosing spondylitis, and acute pain.
According to IMS MAT June, 2014 data, Celebrex capsules had annual US sales of $ 2.44 billion.